Search clinical trials for: Relapsing-remitting MS (RRMS)
Total 21624 results
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
SanofiCompletedMultiple SclerosisHungary, Belgium, Germany, Italy, Greece, France, Poland, Spain, Canada, Switzerland, Czech Republic, Tunisia, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
PD Dr. Marcus MüllerBfARM, Bonn; DZNE, BonnUnknownRelapsing-remitting Multiple SclerosisGermany
-
Nantes University HospitalCompletedRelapsing-remitting Multiple SclerosisFrance
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityCompletedRelapsing-remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityNational Multiple Sclerosis SocietyCompletedRelapsing-remitting Multiple SclerosisUnited States
-
BiogenWithdrawnMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
BayerCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
EMD SeronoTerminated
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
Waukesha Memorial HospitalThe Cleveland ClinicCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Claudio GobbiOspedale Civico, LuganoCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
University of MalagaUnknownRelapsing-remitting Multiple SclerosisSpain
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Claudio GobbiBayerTerminatedRelapsing-remitting Multiple SclerosisSwitzerland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
EMD SeronoWithdrawnRelapsing-Remitting Multiple Sclerosis
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-Remitting
-
Coordinación de Investigación en Salud, MexicoCompleted
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, SwitzerlandCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States
-
BayerCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
Cantonal Hospital of St. GallenUnknownRelapsing-Remitting Multiple SclerosisSwitzerland
-
BiogenCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Institute for Clinical ResearchUnknownRelapsing-Remitting Multiple SclerosisUnited States